Alzheimer's disease revisited
Identifieur interne : 001367 ( PascalFrancis/Corpus ); précédent : 001366; suivant : 001368Alzheimer's disease revisited
Auteurs : P. E. NewmanSource :
- Medical hypotheses [ 0306-9877 ] ; 2000.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
Abstract
In a previous paper, it was suggested that a relative deficiency of essential fatty acids might play a role in the etiology of sporadic or non-familial Alzheimer's disease. A recent article regarding dementia in the Rotterdam Study reinforces this suggestion. It is also hypothesized that this relative deficiency could facilitate passage of aluminum into the brain, aluminum being increasingly suggested as one of the possible pathogenic factors in AD. It is further suggested that hypomethylation caused by a deficiency of S-adenosylmethionine might also play a role in the etiology of this disease and perhaps even of Parkinson's disease.
Notice en format standard (ISO 2709)
Pour connaître la documentation sur le format Inist Standard.
pA |
|
---|
Format Inist (serveur)
NO : | PASCAL 00-0327319 INIST |
---|---|
ET : | Alzheimer's disease revisited |
AU : | NEWMAN (P. E.) |
AF : | 10, Anatole de la Forge, 75017 Paris/France (1 aut.) |
DT : | Publication en série; Niveau analytique |
SO : | Medical hypotheses; ISSN 0306-9877; Royaume-Uni; Da. 2000; Vol. 54; No. 5; Pp. 774-776; Bibl. 9 ref. |
LA : | Anglais |
EA : | In a previous paper, it was suggested that a relative deficiency of essential fatty acids might play a role in the etiology of sporadic or non-familial Alzheimer's disease. A recent article regarding dementia in the Rotterdam Study reinforces this suggestion. It is also hypothesized that this relative deficiency could facilitate passage of aluminum into the brain, aluminum being increasingly suggested as one of the possible pathogenic factors in AD. It is further suggested that hypomethylation caused by a deficiency of S-adenosylmethionine might also play a role in the etiology of this disease and perhaps even of Parkinson's disease. |
CC : | 002B17G |
FD : | Démence Alzheimer; Pathogénie; Déficit; Acide gras; Essentiel; Taux concentration; Aluminium; Encéphale; Prévention; Homme |
FG : | Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Maladie dégénérative; Métabolisme pathologie |
ED : | Alzheimer disease; Pathogenesis; Deficiency; Fatty acids; Essential; Concentration factor; Aluminium; Brain (vertebrata); Prevention; Human |
EG : | Nervous system diseases; Central nervous system disease; Cerebral disorder; Degenerative disease; Metabolic diseases |
SD : | Demencia Alzheimer; Patogenia; Déficiencia; Acido graso; Esencial; Indice concentración; Aluminio; Encéfalo; Prevención; Hombre |
LO : | INIST-18253.354000088753050210 |
ID : | 00-0327319 |
Links to Exploration step
Pascal:00-0327319Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Alzheimer's disease revisited</title>
<author><name sortKey="Newman, P E" sort="Newman, P E" uniqKey="Newman P" first="P. E." last="Newman">P. E. Newman</name>
<affiliation><inist:fA14 i1="01"><s2>10, Anatole de la Forge, 75017 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">00-0327319</idno>
<date when="2000">2000</date>
<idno type="stanalyst">PASCAL 00-0327319 INIST</idno>
<idno type="RBID">Pascal:00-0327319</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001367</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Alzheimer's disease revisited</title>
<author><name sortKey="Newman, P E" sort="Newman, P E" uniqKey="Newman P" first="P. E." last="Newman">P. E. Newman</name>
<affiliation><inist:fA14 i1="01"><s2>10, Anatole de la Forge, 75017 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Medical hypotheses</title>
<title level="j" type="abbreviated">Med. hypotheses</title>
<idno type="ISSN">0306-9877</idno>
<imprint><date when="2000">2000</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Medical hypotheses</title>
<title level="j" type="abbreviated">Med. hypotheses</title>
<idno type="ISSN">0306-9877</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aluminium</term>
<term>Alzheimer disease</term>
<term>Brain (vertebrata)</term>
<term>Concentration factor</term>
<term>Deficiency</term>
<term>Essential</term>
<term>Fatty acids</term>
<term>Human</term>
<term>Pathogenesis</term>
<term>Prevention</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Démence Alzheimer</term>
<term>Pathogénie</term>
<term>Déficit</term>
<term>Acide gras</term>
<term>Essentiel</term>
<term>Taux concentration</term>
<term>Aluminium</term>
<term>Encéphale</term>
<term>Prévention</term>
<term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">In a previous paper, it was suggested that a relative deficiency of essential fatty acids might play a role in the etiology of sporadic or non-familial Alzheimer's disease. A recent article regarding dementia in the Rotterdam Study reinforces this suggestion. It is also hypothesized that this relative deficiency could facilitate passage of aluminum into the brain, aluminum being increasingly suggested as one of the possible pathogenic factors in AD. It is further suggested that hypomethylation caused by a deficiency of S-adenosylmethionine might also play a role in the etiology of this disease and perhaps even of Parkinson's disease.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0306-9877</s0>
</fA01>
<fA03 i2="1"><s0>Med. hypotheses</s0>
</fA03>
<fA05><s2>54</s2>
</fA05>
<fA06><s2>5</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Alzheimer's disease revisited</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>NEWMAN (P. E.)</s1>
</fA11>
<fA14 i1="01"><s2>10, Anatole de la Forge, 75017 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA20><s1>774-776</s1>
</fA20>
<fA21><s1>2000</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>18253</s2>
<s5>354000088753050210</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2000 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>9 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>00-0327319</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Medical hypotheses</s0>
</fA64>
<fA66 i1="01"><s0>GBR</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>In a previous paper, it was suggested that a relative deficiency of essential fatty acids might play a role in the etiology of sporadic or non-familial Alzheimer's disease. A recent article regarding dementia in the Rotterdam Study reinforces this suggestion. It is also hypothesized that this relative deficiency could facilitate passage of aluminum into the brain, aluminum being increasingly suggested as one of the possible pathogenic factors in AD. It is further suggested that hypomethylation caused by a deficiency of S-adenosylmethionine might also play a role in the etiology of this disease and perhaps even of Parkinson's disease.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Démence Alzheimer</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Alzheimer disease</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Demencia Alzheimer</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Pathogénie</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Pathogenesis</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Patogenia</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Déficit</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Deficiency</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Déficiencia</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Acide gras</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Fatty acids</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Acido graso</s0>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Essentiel</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Essential</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Esencial</s0>
<s5>05</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Taux concentration</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Concentration factor</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Indice concentración</s0>
<s5>06</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Aluminium</s0>
<s2>NC</s2>
<s2>FR</s2>
<s2>FX</s2>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Aluminium</s0>
<s2>NC</s2>
<s2>FR</s2>
<s2>FX</s2>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Aluminio</s0>
<s2>NC</s2>
<s2>FR</s2>
<s2>FX</s2>
<s5>07</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Encéphale</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Brain (vertebrata)</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Encéfalo</s0>
<s5>08</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Prévention</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Prevention</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Prevención</s0>
<s5>09</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Homme</s0>
<s5>20</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Human</s0>
<s5>20</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Hombre</s0>
<s5>20</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Encéphale pathologie</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Métabolisme pathologie</s0>
<s5>45</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Metabolic diseases</s0>
<s5>45</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Metabolismo patología</s0>
<s5>45</s5>
</fC07>
<fN21><s1>220</s1>
</fN21>
</pA>
</standard>
<server><NO>PASCAL 00-0327319 INIST</NO>
<ET>Alzheimer's disease revisited</ET>
<AU>NEWMAN (P. E.)</AU>
<AF>10, Anatole de la Forge, 75017 Paris/France (1 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Medical hypotheses; ISSN 0306-9877; Royaume-Uni; Da. 2000; Vol. 54; No. 5; Pp. 774-776; Bibl. 9 ref.</SO>
<LA>Anglais</LA>
<EA>In a previous paper, it was suggested that a relative deficiency of essential fatty acids might play a role in the etiology of sporadic or non-familial Alzheimer's disease. A recent article regarding dementia in the Rotterdam Study reinforces this suggestion. It is also hypothesized that this relative deficiency could facilitate passage of aluminum into the brain, aluminum being increasingly suggested as one of the possible pathogenic factors in AD. It is further suggested that hypomethylation caused by a deficiency of S-adenosylmethionine might also play a role in the etiology of this disease and perhaps even of Parkinson's disease.</EA>
<CC>002B17G</CC>
<FD>Démence Alzheimer; Pathogénie; Déficit; Acide gras; Essentiel; Taux concentration; Aluminium; Encéphale; Prévention; Homme</FD>
<FG>Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Maladie dégénérative; Métabolisme pathologie</FG>
<ED>Alzheimer disease; Pathogenesis; Deficiency; Fatty acids; Essential; Concentration factor; Aluminium; Brain (vertebrata); Prevention; Human</ED>
<EG>Nervous system diseases; Central nervous system disease; Cerebral disorder; Degenerative disease; Metabolic diseases</EG>
<SD>Demencia Alzheimer; Patogenia; Déficiencia; Acido graso; Esencial; Indice concentración; Aluminio; Encéfalo; Prevención; Hombre</SD>
<LO>INIST-18253.354000088753050210</LO>
<ID>00-0327319</ID>
</server>
</inist>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001367 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 001367 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= ParkinsonFranceV1 |flux= PascalFrancis |étape= Corpus |type= RBID |clé= Pascal:00-0327319 |texte= Alzheimer's disease revisited }}
This area was generated with Dilib version V0.6.29. |